Orthofix Int'l (OFIX) Prelim. FY15 Revenue Edges-Out Expectations
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/18/2026
- Wall Street tumbles as worries about AI trade and high oil prices weigh
- Oil touches $110 a barrel for first time since May on Middle East, Russia supply fears
- Stay risk-off as higher real yields and AI volatility threaten stocks: BofA
- Appleās first foldable iPhone sells out within minutes as preorders begin
- CoreWeave bond rout tests market's math on AI buildout
- Yorkville Ives: 'GameStop Is Becoming the Hobby's Intake Network'
- Wall Street tumbles as worries about AI trade and high oil prices weigh
- Micron Technology stock drops on China chip news and labor dispute
- Truist Financial to sell $7.7B LightStream loan portfolio to Carlyle
- Truist Financial to sell $7.7B LightStream loan portfolio to Carlyle
Orthofix Announces Preliminary Fourth Quarter 2015 and Full Year Net Sales Results
January 12, 2016 4:00 PM ESTLEWISVILLE, Texas--(BUSINESS WIRE)-- Orthofix International N.V. (NASDAQ: OFIX), a diversified, global medical device company, today announced preliminary unaudited fourth quarter 2015 net sales of approximately $105 million. These preliminary results represent a reported sales growth of 4.3% and constant currency sales growth of 7.6% over the fourth quarter 2014. For the full year 2015, preliminary unaudited net sales were approximately $396 million, which decreased 1.4% on a reported basis and increased 2.4% on a constant currency basis over the full year 2014.
  Three Months Ended December 31, (Unaudited, U.S. Dollars, in millions)2015
  2014  ÂReportedGrowth
 ÂConstantCurrencyGrowth
BioStim$
45
$ 40 Â13
% Â13
% Biologics... More


